The ranking highlights a period of rapid expansion for the brand, which now operates in more than 200 communities nationwide. Founder and CEO Amy Neary attributes the company's sustained trajectory to the performance of its franchise owners and a rising consumer appetite for proactive, medically guided wellness services. The company currently provides a range of treatments including micronutrient injections and NAD+ therapy, catering to clients seeking support for athletic recovery, immune health, and cognitive function.
To qualify for the Inc. 5000, companies must demonstrate significant revenue growth, maintain independence, and meet strict financial thresholds, including a minimum revenue of $2 million by the end of 2025. Prime IV’s inclusion in the list follows its consistent recognition by industry publications, including a three-year streak as the top-ranked IV therapy franchise in Entrepreneur’s Franchise 500. The company plans to celebrate these results alongside other honorees at the upcoming Inc. 5000 Conference & Gala in Dallas this October.
Comments (0)
No comments yet. Be the first!